Stressors caused by the Covid-19 crisis continue to impact thousands of New York’s independent pharmacies as well as millions of patients in underserved communities who rely on their pharmacy for accessible health care.
But vastly overshadowing the challenges to pharmacies posed by pandemic labor shortages and supply-chain issues are prescription drug middlemen, who are taking billions of dollars from New York pharmacists and taxpayers, raking in outlandish profits.
That’s why pharmacists cheered Gov. Kathy Hochul when she signed into law on New Year’s Eve landmark legislation dubbed by the news media as the “nation’s toughest crackdown” on pharmacy benefit managers, or PBMs, as the middlemen are known. Hochul’s
→ Continue reading at Crain's New York Business
